ANNAMARIA CERMINARA: Open Payments
NPI 1992411920 · CANONSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,059 in 22 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $1,059
Food & beverage: $1,059
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 4 | $270 |
| CeQur Corporation | 1 | $206 |
| Insulet Corporation | 3 | $184 |
| Dexcom, Inc. | 1 | $137 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Novo Nordisk Inc | 2 | $44 |
| Medtronic, Inc. | 2 | $42 |
| Antares Pharma, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| Corcept Therapeutics | 1 | $21 |
Products named: t:slim X2 Insulin Pump with Control-IQ, CeQur Simplicity, OMNIPOD, Dexcom G6 Transmitter, CRENESSITY, Rybelsus, MINIMED 780G, XYOSTED.
Industry payments across PA — which companies pay providers there.
